Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May;392(2):431-442.
doi: 10.1007/s00441-023-03748-8. Epub 2023 Feb 4.

Hyperlipidemia in tendon injury: chronicles of low-density lipoproteins

Affiliations
Review

Hyperlipidemia in tendon injury: chronicles of low-density lipoproteins

William H Fang et al. Cell Tissue Res. 2023 May.

Abstract

Hyperlipidemia impacts millions of people globally and has been the major risk factor for developing atherosclerosis and cardiovascular disease. Interestingly, hyperlipidemic subjects exhibit increased incidence of rotator cuff tendon injury (RCTI) and disorganization of tendon matrix. Low-density lipoproteins (LDL) and its oxidized form (ox-LDL) play a crucial role in hyperlipidemia-driven pro-inflammatory responses in multiple tissues including the tendon. The signaling of oxLDL upregulates the inflammatory cytokines, chemokines, adhesion molecules, and the activation of monocytes/macrophages/resident tendon cells and matrix metalloproteinases impairing the tendon homeostasis resulting in the alteration of extracellular matrix. In addition, the hyperlipidemia-driven immune response and subsequent oxidative stress promote degenerative responses in the tendon tissue. However, the pathological mechanisms underlying the occurrence of RCTI in hyperlipidemia and the effect of ox-LDL in tendon matrix are currently unknown. The present review focuses on the implications and perspectives of LDL/oxLDL on the increased incidence of RCTI.

Keywords: ECM disorganization; Hyperlipidemia; LDL; Rotator cuff tendon injury; oxLDL.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
LDL molecular formation pathway from precursor lipid species. The molecular events involve binding of LDL particle on the plasma membrane, followed by internalization, and routing to the lysosome for degradation into fatty acids. However, an overabundance of LDL leads to atherogenesis through the formation of foam cells, lipid-laden macrophages, that localize on blood vessel walls
Fig. 2
Fig. 2
(Left panel) Oxidative molecules and free radicals lead to OxLDL formation. OxLDL increases inflammatory cytokines and polarizes macrophages to M2 phenotype. (Right panel) Downstream signaling of OxLDL and M2 leading to collagen disruption and angiogenesis
Fig. 3
Fig. 3
The intracellular macrophage activation leading to the increased production of proinflammatory cytokines and ROS. Cholesterol reacts with ROS to activate AKT/FOXO1 signaling leading to the histological alterations including degenerative damage in the tendon

References

    1. Abboud JA, Kim JS (2010) The effect of hypercholesterolemia on rotator cuff disease. Clin Orthop Relat Res® 468:1493–1497 - PMC - PubMed
    1. Al Jasmi F, Galadari H, Clayton PT, Footitt EJ (2019) Metabolic disorders and the skin. Harper’s Textbook of Pediatric Dermatology 1965–1987
    1. Artieda M, Cenarro A, Junquera C, Lasierra P, Martínez-Lorenzo MJ, Pocoví M, Civeira F. Tendon xanthomas in familial hypercholesterolemia are associated with a differential inflammatory response of macrophages to oxidized LDL. FEBS Lett. 2005;579:4503–4512. - PubMed
    1. Balakumar P, Maung-U K, Jagadeesh G. Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol Res. 2016;113:600–609. - PubMed
    1. Bath SS, Bath S, Tehranzahdeh J (2010) Xanthomatous infiltration of the rotator cuff and long head of biceps with rotator cuff tear in a patient with mixed hyperlipidemia: a case report with MRI imaging. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 3:CMAMD. S3172 - PMC - PubMed

Substances